The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Growth In Market Value Is Anticipated For The Genomic And Proteomic Tool Market Between 2026 And 2030?
The market size for genomic and proteomic tools has seen rapid expansion recently. It is forecast to grow from $33.14 billion in 2025 to $37 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. Historically, this growth can be attributed to increased funding for genomic research, the proliferation of NGS technologies, an escalation in pharmaceutical R&D, heightened academic research activities, and a reduction in sequencing costs.
The genomic and proteomic tool market size is anticipated to undergo significant expansion in the coming years. It is projected to reach $56.95 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.4%. The projected growth during this period can be attributed to several factors, including the advancement of precision medicine, wider adoption of clinical genomics, an increasing demand for proteomics in drug discovery, the expansion of personalized diagnostics, and improvements in bioinformatics tools. Noteworthy trends for the forecast period encompass the embrace of high-throughput sequencing, the development of integrated multi-omics platforms, increased automation in sample preparation, the proliferation of cloud-based bioinformatics, and the broadened scope of biomarker discovery.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28235&type=smp
Which Core Factors Are Supporting The Expansion Of The Genomic And Proteomic Tool Market?
The expanded use of personalized medicine is anticipated to fuel the expansion of the genomic and proteomic tool market going forward. This approach involves customizing prevention, diagnosis, and treatment based on an individual’s molecular profile, utilizing biomarkers derived from deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins. Its growing acceptance stems from progress in genomics, proteomics, and biomarker discovery, which facilitates customized treatments informed by unique genetic profiles. These advancements boost the demand for targeted therapies, enhanced diagnostics, and precise healthcare options, having enabled the creation of specialized treatments and more accurate diagnostic tools tailored to a patient’s genetic makeup. Genomic and proteomic tools are vital in this process, identifying genetic variations and protein biomarkers, thereby allowing clinicians to optimize treatments and improve patient outcomes. For instance, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that the USFDA approved 16 new personalized treatments for rare disease patients in 2023, a significant increase from 6 personalized treatments in 2022. Consequently, the expanding adoption of personalized medicine is propelling the genomic and proteomic tool market.
What Are The Core Segment Classifications In The Genomic And Proteomic Tool Market?
The genomic and proteomic tool market covered in this report is segmented –
1) By Product Type: Instruments, Consumables, Software, Services
2) By Technology: Sequencing, Microarray, Polymerase Chain Reaction (PCR), Mass Spectrometry, Electrophoresis, Chromatography
3) By Workflow Stage: Sample Preparation, Library Preparation, Data Analysis, Reporting
4) By Application: Drug Discovery, Diagnostics, Personalized Medicine, Agriculture And Animal Research
5) By End User: Academic And Research Institutions, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Healthcare Providers
Subsegments:
1) By Instruments: DNA Sequencing Systems, Polymerase Chain Reaction (PCR) Systems, Microarray Analyzers, Mass Spectrometry Instruments, Electrophoresis Systems, Chromatography Instruments, Flow Cytometers
2) By Consumables: Reagents And Kits, Assay Kits, Sample Preparation Consumables, Sequencing Consumables, Protein Assay Reagents, Microarray Chips, Laboratory Chemicals
3) By Software: Genomic Data Analysis Software, Proteomic Data Analysis Software, Bioinformatics Platforms, Clinical Data Interpretation Tools, Workflow Management Software, Cloud-based Analysis Platforms
4) By Services: Next-Generation Sequencing (NGS) Services, Gene Expression And Genotyping Services, Protein Identification And Quantification Services, Biomarker Discovery Services, Structural Biology Analysis Services, Bioinformatics And Data Interpretation Services, Molecular Diagnostics Services
Which Trends Are Influencing The Direction Of The Genomic And Proteomic Tool Market?
Leading companies in the genomic and proteomic tools market are concentrating their efforts on innovation via spatial multi-omics technologies. These advancements facilitate the in-situ, same-cell identification of RNA and proteins, thereby integrating various molecular data layers, maintaining tissue architecture, and accelerating discovery processes. Spatial multi-omics entails the simultaneous measurement of gene expression and protein markers within intact tissue at a single-cell or subcellular resolution, providing deeper biological understandings compared to assays that use only one modality. As an illustration, in August 2025, 10x Genomics, a biotechnology firm based in the U.S., launched Xenium Protein, a pioneering assay designed for single-cell RNA and protein analysis on the Xenium in situ platform. This solution offers an integrated, single-instrument workflow, removing the necessity for data integration across multiple platforms, and includes pre-validated, convenient protein subpanels to simplify both setup and quality control. Such progress empowers researchers to preserve spatial context while broadening biomarker panels for applications such as validating targets, classifying patients, and studying mechanisms of action.
Who Are The Companies Shaping The Genomic And Proteomic Tool Market Landscape?
Major companies operating in the genomic and proteomic tool market are F. HoffmannLa Roche, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE Healthcare, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bruker Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., PerkinElmer Inc., Promega, Novogene Corp., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Sophia Genetics, LC Sciences
Access The Complete Genomic And Proteomic Tool Market Report:
https://www.thebusinessresearchcompany.com/report/genomic-and-proteomic-tool-global-market-report
Which Region Leads The Genomic And Proteomic Tool Market By Size?
North America was the largest region in the genomic and proteomic tool market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomic and proteomic tool market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Genomic And Proteomic Tool Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/report/genomic-and-proteomic-tool-global-market-report
Browse Through More Reports Similar to the Global Genomic And Proteomic Tool Market 2026, By The Business Research Company
Genomics Market Report 2026
https://www.thebusinessresearchcompany.com/report/genomics-global-market-report
Genomics Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report
Metagenomics Market Report 2026
https://www.thebusinessresearchcompany.com/report/metagenomics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model